ATRA vs GIS · rev $128.9M vs P/E 8.2, rev $4.56B
Atara Biotherapeutics Inc (ATRA) versus General Mills Inc (GIS) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported GIS revenue for 2025-05-25 was $4.56B. Net income was $2.32B. Revenue was down 5.9% from 2025-02-23 to 2025-05-25. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
ATRA currently screens at market cap $87.1M. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Not investment advice. Open the ATRA and GIS stock pages for the full models.
Not investment advice.